Study on Tumor Blood Flow Shutdown with CA4P
Author Information
Author(s): Gaya A, Daley F, Taylor N J, Tozer G, Qureshi U, Padhani A, Pedley R B, Begent R, Wellsted D, Stirling J J, Rustin G
Primary Institution: Guy's & St Thomas' Hospitals
Hypothesis
Can the histological angiogenic profile explain the sensitivity of human tumors to CA4P?
Conclusion
The study found no strong relationships between changes in DCE-MRI kinetic variables following CA4P and the immunohistochemical angiogenic profile.
Supporting Evidence
- Three patients showed a statistically significant fall in Ktrans following CA4P.
- One patient showed a statistically significant fall in IAUGC60.
- No statistically significant correlations were seen between the continuous or categorical variables and the DCE-MRI kinetic parameters.
Takeaway
This study looked at how a drug affects blood flow in tumors, but it didn't find a clear link between the tumor's blood vessel characteristics and how well the drug worked.
Methodology
The study involved analyzing tissue samples from patients and using dynamic MRI to assess changes in blood flow after administering CA4P.
Potential Biases
Potential bias due to the retrospective nature of the study and the variability in tumor characteristics.
Limitations
The sample size was small and included a heterogeneous mix of tumor types, which may limit the conclusions.
Participant Demographics
Mean age 59, range 32–73, with 18 women and 6 men.
Statistical Information
P-Value
0.044
Confidence Interval
−62.5 to +166.5%
Statistical Significance
p=0.044
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website